Who invested in Vitarka Therapeutics?

Investors on record for Vitarka Therapeutics: IndieBio.

Who founded Vitarka Therapeutics?

Vitarka Therapeutics was founded by Vineeta Tripathi (founding CEO).

Vitarka Therapeutics

Vitarka Therapeutics has engineered an intracellular drug delivery technology, EndoPore, using pore forming proteins for intracellular targets.

Website: vitarka.co.uk.

Categories: Health and bio Logistics and mobility.

Domain age: 5 years.

On Recent Funding since: Oct 11, 2026.

About Vitarka Therapeutics

Recent Funding lists Vitarka Therapeutics under Health and bio (also Logistics and mobility). It went through IndieBio (IndieBio NY 05). It was founded by Vineeta Tripathi.

Funding rounds

IndieBio NY 05
IIndieBio · batch
Source: indiebio.co
March 19, 2021
Website created

Founders and team

VT
Vineeta Tripathi founding CEO

source: vitarka.co.uk

Investors

IIndieBioaccelerator

Similar Health and bio companies

HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026

Questions and sources

Vitarka Therapeutics: questions and answers

Who invested in Vitarka Therapeutics?: Investors on record for Vitarka Therapeutics: IndieBio.
Who founded Vitarka Therapeutics?: Vitarka Therapeutics was founded by Vineeta Tripathi (founding CEO).

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/vitarka-therapeutics (get a free API key).